ProPhase Labs Ownership | Who Owns ProPhase Labs?


OverviewRevenueFinancialsChartTranscripts

ProPhase Labs Ownership Summary


ProPhase Labs is owned by 5.47% institutional investors, 7.99% insiders, and 86.54% retail investors. Sykon capital is the largest institutional shareholder, holding 1.55% of PRPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.50% of its assets in ProPhase Labs shares.

PRPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockProPhase Labs5.47%7.99%86.54%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sykon capital644.79K1.55%$295.19K
Vanguard group531.92K1.28%$243.62K
Geode capital management302.93K0.73%$138.70K
Accretive wealth partners250.00K0.60%$114.45K
Hightower advisors237.34K0.57%$108.65K
Apollon wealth management182.46K0.44%$83.53K
Blackrock64.30K0.36%$268.77K
Susquehanna group, llp46.95K0.25%$35.55K
Bank of america corp /de/36.72K0.20%$153.49K
Chapin davis80.00K0.19%$36.62K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sykon capital644.79K0.10%$295.19K
Accretive wealth partners250.00K0.03%$114.45K
Chapin davis80.00K0.01%$36.62K
Two sigma securities47.47K0.00%$21.73K
Apollon wealth management182.46K0.00%$83.53K
Xtx topco28.77K0.00%$13.17K
Nordwand advisors10.00K0.00%$4.58K
Forvis wealth advisors19.60K0.00%$8.97K
Annex advisory services15.00K0.00%$6.87K
Hightower advisors237.34K0.00%$108.65K

Top Buyers

HolderShares% AssetsChange
Accretive wealth partners250.00K0.03%250.00K
Apollon wealth management182.46K0.00%182.46K
Vanguard group531.92K-123.65K
Geode capital management302.93K-43.87K
Simplex trading40.60K-28.98K

Top Sellers

HolderShares% AssetsChange
Wexford capital lp---1.53M
Fourworld capital management---376.58K
Citizens financial group inc/ri---270.40K
Josh arnold investment consultant---250.00K
Quinn opportunity partners---218.13K

New Positions

HolderShares% AssetsChangeValue
Accretive wealth partners250.00K0.03%250.00K$114.45K
Apollon wealth management182.46K0.00%182.46K$83.53K
Annex advisory services15.00K0.00%15.00K$6.87K
Cambridge investment research advisors14.79K-14.79K$7.00K
Group one trading705.00-705.00$2.95K

Sold Out

HolderChange
Qube research-25.00
Spire wealth management-80.00
Tower research capital llc (trc)-116.00
Capital advisors-190.00
Raymond james financial-198.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202525-19.35%2,273,605-14.81%513.26%13-13.33%3-50.00%
Jun 30, 202533-10.81%2,677,960-46.38%60.94%17-15.00%6-25.00%
Mar 31, 20253723.33%4,994,566106.49%2616.29%2025.00%860.00%
Dec 31, 202419-24.00%2,139,09122.33%1113.35%129.09%2-33.33%
Sep 30, 202425-16.67%1,748,6470.58%99.87%11-8.33%3-57.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv454.64K1.50%-
Vanguard US Total Market Shares ETF454.64K1.09%-
Vanguard Institutional Extnd Mkt Idx Tr285.99K0.69%-118.22K
Fidelity Extended Market Index175.60K0.42%35.36K
Perritt MicroCap Opportunities Investor150.00K0.36%-40.00K
BlackRock Extended Equity Market K23.33K0.12%-10.00
Belfund SICAV Belinvest Equity A USD Acc50.00K0.12%-
Perritt Ultra MicroCap20.00K0.10%-
Fidelity Series Total Market Index40.38K0.10%-
iShares Micro-Cap ETF33.93K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Mar 10, 2022Barr Jason Michael-Buy$4.67K
Mar 10, 2022Barr Jason Michael Buy$4.86K
Jun 03, 2021Karkus Ted William CEO & CHAIRMANBuy$171.92K
Aug 13, 2020Karkus Ted William CEO & CHAIRMANSell$137.50K
Aug 13, 2020GLECKEL LOUIS MD-Buy$137.50K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q1--
2024 Q1--
2023 Q2--
2023 Q1--

PRPH Ownership FAQ


Who Owns ProPhase Labs?

ProPhase Labs shareholders are primarily institutional investors at 5.47%, followed by 7.99% insiders and 86.54% retail investors. The average institutional ownership in ProPhase Labs's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which ProPhase Labs falls below.

Who owns the most shares of ProPhase Labs?

ProPhase Labs’s largest shareholders are Sykon capital (644.8K shares, 1.55%), Vanguard group (531.92K shares, 1.28%), and Geode capital management (302.93K shares, 0.73%). Together, they hold 3.56% of ProPhase Labs’s total shares outstanding.

Does Blackrock own ProPhase Labs?

Yes, BlackRock owns 0.36% of ProPhase Labs, totaling 64.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 268.77K$. In the last quarter, BlackRock increased its holdings by 6.94K shares, a 12.10% change.

Who is ProPhase Labs’s biggest shareholder by percentage of total assets invested?

Sykon capital is ProPhase Labs’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 644.8K ProPhase Labs shares, valued at 295.19K$.

Who is the top mutual fund holder of ProPhase Labs shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ProPhase Labs shares, with 1.50% of its total shares outstanding invested in 454.64K ProPhase Labs shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools